EBAC Stock Overview
European Biotech Acquisition Corp. does not have significant operations.
Notes are coming soon
European Biotech Acquisition Corp. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$10.15|
|52 Week High||US$10.65|
|52 Week Low||US$9.66|
|1 Month Change||0.50%|
|3 Month Change||1.60%|
|1 Year Change||4.10%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||n/a|
Recent News & Updates
|EBAC||US Capital Markets||US Market|
Return vs Industry: EBAC exceeded the US Capital Markets industry which returned -13.5% over the past year.
Return vs Market: EBAC exceeded the US Market which returned -13.6% over the past year.
|EBAC Average Weekly Movement||0.3%|
|Capital Markets Industry Average Movement||0.6%|
|Market Average Movement||6.9%|
|10% most volatile stocks in US Market||17.3%|
|10% least volatile stocks in US Market||2.8%|
Stable Share Price: EBAC is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 0% a week.
Volatility Over Time: EBAC's weekly volatility (0%) has been stable over the past year.
About the Company
|2021||n/a||Eduardo Bravo de Araoz||https://www.lspvc.com/ebac|
European Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on business in the life sciences industry in Europe.
European Biotech Acquisition Corp. Fundamentals Summary
|EBAC fundamental statistics|
Is EBAC overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|EBAC income statement (TTM)|
|Cost of Revenue||US$0|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.052|
|Net Profit Margin||0.00%|
How did EBAC perform over the long term?See historical performance and comparison